Bright Minds Biosciences Inc. · CSE:DRUG
Cormorant Asset Management, LP sold 109,331 Bright Minds Biosciences Inc. shares (Form 4)
Traded Apr 28, 2026 · Filed Apr 30, 2026
On Apr 28, 2026, Cormorant Asset Management, LP (Former 10% Owner) sold 109,331 Bright Minds Biosciences Inc. shares at US$89.50 for US$9.79M, leaving 950,000 shares. Filed Apr 30, 2026 (Form 4).
- Sold
- 109,331 shares
- Price
- US$89.50
- Value
- US$9.79M
- Holding after
- 950,000 shares (held indirectly)
- Trading plan
- No
- Role
- Former 10% Owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | Common Shares | Sale | 109,331 | US$89.50 | 950,000 | Indirect |
Source
Related
- Bright Minds Biosciences Inc.
- Cormorant Asset Management, LP
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026